PEAK6’s AbbVie ABBV Stock Holding History

PEAK6’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	-$456	–	2760
2025 Q3	$526	Buy	+2	New	+$407	﹤0.01%	2859
2025 Q2	–	Sell	-2	Closed	-$372	–	2908
2025 Q1	$516	Sell	2 -9,175	-100%	-$1.78M	﹤0.01%	2910
2024 Q4	$1.63M	Buy	+9,177	New	+$1.69M	﹤0.01%	1538

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PEAK6's ABBV Position: Q4 2025 in Review

PEAK6 sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 2 shares — an estimated $456 sold.

PEAK6 first reported a position in ABBV in Q4 2024 and held it in 3 quarters. The position peaked at $1.63M in Q4 2024. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

PEAK6 reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
PEAK6 sold 2 AbbVie shares in Q4 2025, an estimated $456.
PEAK6 first reported a position in AbbVie in Q4 2024 and held it in 3 quarters.
PEAK6's AbbVie position peaked at $1.63M in Q4 2024.
4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on PEAK6's 13F filing for Q4 2025, filed 13 Feb 2026.